"The European Medicines Agency (EMA) has approved mepolizumab (Nucala, GlaxoSmithKline) as an add-on treatment for severe refractory eosinophilic asthma in adults in the 31 European countries covered by the EMA, according to a company state"...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
OMALIZUMAB - INJECTION
COMMON BRAND NAME(S): Xolair
WARNING: This medication can cause a very serious (sometimes fatal) allergic reaction. In many cases, this type of reaction occurred after the first dose, but it can occur with any later doses. This type of reaction usually occurred within 24 hours or up to 4 days after receiving this medication. Your health care professional will monitor you closely during treatment for any signs of an allergic reaction. Seek immediate medical attention if at any time you develop any signs of an allergic reaction including: trouble breathing, cough, chest tightness, rash, itching, swelling (especially of the throat, tongue), hives, dizziness.
If you have had an allergic reaction to omalizumab, you must never use omalizumab again.
USES: This medication is used to treat moderate to severe asthma or ongoing hives from an unknown cause (chronic idiopathic urticaria-CIU) in adults and children over 12 years of age. It works by blocking your immune system's natural response to allergic triggers that can lead to an acute asthma attack or hives. This effect on your immune system (specifically immunoglobulin E-IgE) helps keep your air passages open and, over time, it keeps your asthma in better control. For CIU, omalizumab helps to reduce itching and number of hives on your skin.
This medication does not work immediately and should not be used for the quick relief of an acute asthma attack.
HOW TO USE: Read the Medication Guide provided by your pharmacist before you start using omalizumab and each time you get a refill. If you have any questions, consult your doctor or pharmacist.
For the treatment of asthma, this medication is injected under the skin (subcutaneously-SC) by a health care professional, usually every 2 or 4 weeks as directed by your doctor. The dosage is based on your body weight and blood level of IgE antibody, as well as your medical condition and response to therapy. Contact your doctor if you have a significant change in body weight during treatment. Your dose may need to be adjusted.
For the treatment of CIU, this medication is injected under the skin by a health care professional. It is given as directed by your doctor, usually every 4 weeks. The dosage is based on your medical condition and response to treatment.
Use this medication regularly in order to get the most benefit from it. To help you remember, use it on the same day of the week according to your schedule. It may take up to several months of continued use to see improvement in your condition.
Do not stop any of your asthma or CIU medications without consulting your doctor. Your condition may become worse if your asthma or CIU drugs are abruptly stopped. Any decrease of your medications (such as corticosteroids, antihistamines) should be done gradually, under the supervision of your doctor.
Additional Xolair Information
Xolair - User Reviews
Xolair User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.